Evidence map›Paper›PMID 28048979›Full record

ArticleNeurotoxicology2017

Adult hippocampal neurogenesis is impaired by transient and moderate developmental thyroid hormone disruption.

M E Gilbert, J H Goodman, J Gomez, A F M Johnstone, R L Ramos

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

M E GilbertToxicity Assessment Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: gilbert.mary@epa.gov.
J H GoodmanDepartment of Developmental Neurobiology, NY State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA; Departments of Physiology and Pharmacology and Neurology, SUNY Downstate Medical Center Brooklyn, NY 11203, USA.
J GomezDepartment of Developmental Neurobiology, NY State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA.
A F M JohnstoneToxicity Assessment Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC, USA.
R L RamosDepartment of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY 11568, USA.
Environmental Protection Agency · USNew York Institute of Technology · USNew York State Office for People With Developmental Disabilities · USSUNY Downstate Health Sciences University · US

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

The hippocampus maintains a capacity for neurogenesis throughout life, a capacity that is reduced in models of adult onset hypothyroidism. The effects of developmental thyroid hormone (TH) insufficiency on neurogenesis in the adult hippocampus, however, has not been examined. Graded degrees of TH insufficiency were induced in pregnant rat dams by administration of 0, 3 or 10ppm of 6-propylthiouracil (PTU) in drinking water from gestational day (GD) 6 until weaning. Body, brain, and hippocampal weight were reduced on postnatal day (PN) 14, 21, 78 and hippocampal volume was smaller at the 10 but not 3ppm dose level. A second experiment examined adult hippocampal neurogenesis following developmental or adult onset hypothyroidism. Two male offspring from 0 and 3ppm exposed dams were either maintained on control water or exposed to 3ppm PTU to create 4 distinct treatment conditions (Control-Control; Control-PTU, PTU-Control, PTU-PTU) based on developmental and adult exposures. Beginning on the 28th day of adult exposure to 0 or 3ppm PTU, bromodeoxyuridine (BrdU, 50mg/kg, ip) was administered twice daily for 5days, and one male from each treatment was sacrificed 24h and 28days after the last BrdU dose and brains processed for immunohistochemistry. Although no volume changes were seen in the hippocampus of the neonate at 3ppm, thinning of the granule cell layer emerged in adulthood. Developmental TH insufficiency produced a reduction in newly born cells, reducing BrdU+ve cells at 1 with no further reduction at 28-days post-BrdU. Similar findings were obtained using the proliferative cell marker Ki67. Neuronal differentiations was also altered with fewer doublecortin (Dcx) expressing cells and a higher proportion of immature Dcx phenotypes seen after developmental but not adult TH insufficiency. An impaired capacity for neurogenesis may contribute to impairments in synaptic plasticity and cognitive deficits previously reported by our laboratory and others following moderate degrees of developmental TH insufficiency induced by this PTU model.

Indexed as

Analysis of VarianceAnimalsAnimals, NewbornAntimetabolitesBromodeoxyuridineCell CountCell DifferentiationDisease Models, AnimalDose-Response Relationship, DrugDoublecortin Domain ProteinsDoublecortin ProteinFemaleHippocampusHypothyroidismKi-67 AntigenMicrotubule-Associated ProteinsAntimetabolitesBromodeoxyuridineDcx protein, ratDoublecortin Domain ProteinsDoublecortin ProteinKi-67 AntigenMicrotubule-Associated ProteinsNeuropeptidesPropylthiouracilThyroid HormonesBrain developmentDentate gyrusDevelopmental neurotoxicityHippocampusHypothyroidismNeurogenesisThyroid hormone

Identifiers

PMID28048979
PMCPMC11242631
OpenAlexW2566525127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.